Compare TKR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKR | ALKS |
|---|---|---|
| Founded | 1899 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.5B |
| IPO Year | 1994 | 2012 |
| Metric | TKR | ALKS |
|---|---|---|
| Price | $99.62 | $27.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $101.20 | $43.43 |
| AVG Volume (30 Days) | 735.9K | ★ 1.7M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.11 | 1.43 |
| Revenue | $80,100,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $4.37 | $24.06 |
| Revenue Next Year | $3.85 | $4.53 |
| P/E Ratio | $25.18 | ★ $19.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.20 | $25.17 |
| 52 Week High | $111.39 | $36.32 |
| Indicator | TKR | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 28.59 |
| Support Level | $70.67 | $25.65 |
| Resistance Level | $111.19 | $28.75 |
| Average True Range (ATR) | 3.20 | 1.09 |
| MACD | -1.40 | -0.38 |
| Stochastic Oscillator | 19.95 | 8.03 |
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.